DLA PharmaceuticalsTypically replies within 1 hour

DLA Pharmaceuticals is a dynamic and research-driven pharmaceutical company dedicated to advancing scientific discovery by providing high-quality, research-grade products.
Our mission is to support scientists, academic institutions, and biotech industries with reliable tools that enable breakthrough innovations in medicine, biotechnology, and life sciences.

Quick Links

Home
Products
About Us
Contact

Resources

Blog
Search Products
Categories

Contact Us

+91 9899965625
sales@dlapharmaceuticals.com info@dlapharmaceuticals.com
201, 2nd floor, Eldeco Center, Block A
Shivalik Colony, Malviya Nagar, South Delhi
New Delhi, 110017

Terms and Conditions
Privacy Policy

DLA PharmaceuticalsTypically replies within 1 hour

+91 9899965625

DLA PharmaceuticalsTypically replies within 1 hour

Quick Links

Home
Products
About Us
Contact

Resources

Blog
Search Products
Categories

Contact Us

+91 9899965625
sales@dlapharmaceuticals.com info@dlapharmaceuticals.com
201, 2nd floor, Eldeco Center, Block A
Shivalik Colony, Malviya Nagar, South Delhi
New Delhi, 110017

Terms and Conditions
Privacy Policy

DLA PharmaceuticalsTypically replies within 1 hour

Human DNMT1 (?exons3-5/?exons3-5) DNMT3B (-/-); CDKN2A (sil/-) HCT116 Cell Line | DLA Pharmaceuticals

Cell Lines & MediaSecondary Cell Lines

Human DNMT1 (?exons3-5/?exons3-5) DNMT3B (-/-); CDKN2A (sil/-) HCT116 Cell Line

CAT Number

ABC-KH4347

Unit Size

1 vial

Updated

March 16, 2026

Product Description

Product Category: Transfected Stable Cell Lines|Knockout Stable Cell Lines Product Type: Knockout Stable Cell Line Recommended Medium & Supplement: Growth Medium: RPMI 1640, 10% FBS

Secondary Cell Lines

Interested in this product?

Contact our team for pricing, availability, and technical support.

Human DNMT1 (?exons3-5/?exons3-5) DNMT3B (-/-); CDKN2A (sil/-) HCT116 Cell Line

Product Description

Secondary Cell Lines

Interested in this product?

Browse More Products